These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 24509086)

  • 1. Considerations on manganese (Mn) treatments for in vitro studies.
    Bowman AB; Aschner M
    Neurotoxicology; 2014 Mar; 41():141-2. PubMed ID: 24509086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of magnetic resonance imaging (MRI) in the study of manganese neurotoxicity.
    Fitsanakis VA; Zhang N; Avison MJ; Gore JC; Aschner JL; Aschner M
    Neurotoxicology; 2006 Sep; 27(5):798-806. PubMed ID: 16620989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of manganese-associated neurotoxicity.
    Racette BA; Aschner M; Guilarte TR; Dydak U; Criswell SR; Zheng W
    Neurotoxicology; 2012 Aug; 33(4):881-6. PubMed ID: 22202748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State-of-the-science review: Does manganese exposure during welding pose a neurological risk?
    Santamaria AB; Cushing CA; Antonini JM; Finley BL; Mowat FS
    J Toxicol Environ Health B Crit Rev; 2007; 10(6):417-65. PubMed ID: 17710609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Astrocytes in Manganese Neurotoxicity Revisited.
    Ke T; Sidoryk-Wegrzynowicz M; Pajarillo E; Rizor A; Soares FAA; Lee E; Aschner M
    Neurochem Res; 2019 Nov; 44(11):2449-2459. PubMed ID: 31571097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Manganese-induced neurotoxicity: a review of its behavioral consequences and neuroprotective strategies".
    Peres TV; Schettinger MR; Chen P; Carvalho F; Avila DS; Bowman AB; Aschner M
    BMC Pharmacol Toxicol; 2016 Nov; 17(1):57. PubMed ID: 27814772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manganese in manganism, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, and Batten disease: A narrative review.
    Proudfoot O
    Neurol India; 2017; 65(6):1241-1247. PubMed ID: 29133694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manganese and Parkinson's disease: a critical review and new findings.
    Guilarte TR
    Environ Health Perspect; 2010 Aug; 118(8):1071-80. PubMed ID: 20403794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manganese and its role in Parkinson's disease: from transport to neuropathology.
    Aschner M; Erikson KM; Herrero Hernández E; Tjalkens R
    Neuromolecular Med; 2009; 11(4):252-66. PubMed ID: 19657747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative damage and neurodegeneration in manganese-induced neurotoxicity.
    Milatovic D; Zaja-Milatovic S; Gupta RC; Yu Y; Aschner M
    Toxicol Appl Pharmacol; 2009 Oct; 240(2):219-25. PubMed ID: 19607852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are there common biochemical and molecular mechanisms controlling manganism and parkisonism.
    Roth JA
    Neuromolecular Med; 2009; 11(4):281-96. PubMed ID: 19757210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manganese-Induced Parkinsonism and Parkinson's Disease: Shared and Distinguishable Features.
    Kwakye GF; Paoliello MM; Mukhopadhyay S; Bowman AB; Aschner M
    Int J Environ Res Public Health; 2015 Jul; 12(7):7519-40. PubMed ID: 26154659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manganese-induced neurotoxicity: the role of astroglial-derived nitric oxide in striatal interneuron degeneration.
    Liu X; Sullivan KA; Madl JE; Legare M; Tjalkens RB
    Toxicol Sci; 2006 Jun; 91(2):521-31. PubMed ID: 16551646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Huntington's disease associated resistance to Mn neurotoxicity is neurodevelopmental stage and neuronal lineage dependent.
    Joshi P; Bodnya C; Ilieva I; Neely MD; Aschner M; Bowman AB
    Neurotoxicology; 2019 Dec; 75():148-157. PubMed ID: 31545971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manganese and the brain.
    Tuschl K; Mills PB; Clayton PT
    Int Rev Neurobiol; 2013; 110():277-312. PubMed ID: 24209443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for cortical dysfunction and widespread manganese accumulation in the nonhuman primate brain following chronic manganese exposure: a 1H-MRS and MRI study.
    Guilarte TR; McGlothan JL; Degaonkar M; Chen MK; Barker PB; Syversen T; Schneider JS
    Toxicol Sci; 2006 Dec; 94(2):351-8. PubMed ID: 16968886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of manganese in neurodegenerative diseases.
    Bowman AB; Kwakye GF; Herrero Hernández E; Aschner M
    J Trace Elem Med Biol; 2011 Dec; 25(4):191-203. PubMed ID: 21963226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium Para-aminosalicylic Acid Protected Primary Cultured Basal Ganglia Neurons of Rat from Manganese-Induced Oxidative Impairment and Changes of Amino Acid Neurotransmitters.
    Li SJ; Li Y; Chen JW; Yuan ZX; Mo YH; Lu GD; Jiang YM; Ou CY; Wang F; Huang XW; Luo YN; Ou SY; Huang YN
    Biol Trace Elem Res; 2016 Apr; 170(2):357-65. PubMed ID: 26286965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calpain activation is involved in acute manganese neurotoxicity in the rat striatum in vivo.
    Quintanar L; Montiel T; Márquez M; González A; Massieu L
    Exp Neurol; 2012 Jan; 233(1):182-92. PubMed ID: 21985864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferroportin is a manganese-responsive protein that decreases manganese cytotoxicity and accumulation.
    Yin Z; Jiang H; Lee ES; Ni M; Erikson KM; Milatovic D; Bowman AB; Aschner M
    J Neurochem; 2010 Mar; 112(5):1190-8. PubMed ID: 20002294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.